- Reaction score
They seem to have the simpliest method (wounding and possibly minoxidil) and it takes this long to get a trial started? Tsuji will have his work done before these jokers get out of the starting gate.
" "Developing products to generate new human hair follicles and hair. Clinical stage, expected to enter FDA pivotal/registration studies in the first half of 2017."
" Follica is a clinical stage business utilising its regenerative biology platform technology to develop a novel treatment for hair loss. Follica's technology employs a technique designed to stimulate the growth of new follicles and hair through disruption of the skin, followed by treatment with drugs and chemicals to enhance the effect on these new hair follicles and potentially further develop new hair. Follica has completed three human clinical studies of patients with androgenetic alopecia to demonstrate hair growth and new hair follicle formation following application of its technology. Follica has also performed and funded preclinical work which, together with research from the University of Pennsylvania, serve as the foundational observations on which the technology is based. Follica plans to initiate a registration study in the second half of 2016, with data read-out in 2017. If the data are favourable, Follica would potentially plan to seek FDA clearance in 2017, with commercial release to follow as soon as 2018 ".
It's not really that simple because Follica have different products, and this is not a simpliest method as we can think Maybe Follica expected to enter different clinical trials as a pivotal study (for the different drugs and chemicals?) and another one is called registration study (a study before the release of their device and maybe one of their drug )